Norges Bank’s Arcadia Biosciences RKDA Stock Holding History

Norges Bank’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-39	Closed	-$21K	–	2155
2017 Q1	$21K	Sell	39 -19	-33%	-$13.7K	﹤0.01%	2137
2016 Q4	$43K	Hold	58	–	–	﹤0.01%	2147
2016 Q3	$86K	Hold	58	–	–	﹤0.01%	2143
2016 Q2	$121K	Hold	58	–	–	﹤0.01%	2160
2016 Q1	$130K	Hold	58	–	–	﹤0.01%	2177
2015 Q4	$142K	Sell	58 -5	-8%	-$13K	﹤0.01%	2215
2015 Q3	$152K	Hold	63	–	–	﹤0.01%	2246
2015 Q2	$318K	Buy	+63	New	+$392K	﹤0.01%	2212

Other funds holding RKDA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank's RKDA Position: Q2 2017 in Review

Norges Bank sold out of Arcadia Biosciences (RKDA) in Q2 2017, closing a stake of 39 shares — an estimated $21K sold.

Norges Bank first reported a position in RKDA in Q2 2015 and held it in 8 quarters. The position peaked at $318K in Q2 2015. 15 funds tracked by Wall St. Rank hold RKDA as of Q2 2017.

Norges Bank reported no remaining Arcadia Biosciences position as of Q2 2017 after selling out during the quarter.
Norges Bank sold 39 Arcadia Biosciences shares in Q2 2017, an estimated $21K.
Norges Bank first reported a position in Arcadia Biosciences in Q2 2015 and held it in 8 quarters.
Norges Bank's Arcadia Biosciences position peaked at $318K in Q2 2015.
15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2017.

Based on Norges Bank's 13F filing for Q2 2017, filed 2 Aug 2017.